Zhende Medical(SH:603301) Sou Hu Cai Jing·2025-12-11 00:37Core Viewpoint - The stock of Zhendemedical (603301) experienced a decline of 2.28% on December 10, 2025, closing at 72.37 yuan, with significant net outflows from major funds and a mixed performance from retail investors [1][2]. Group 1: Stock Performance and Trading Data - On December 10, 2025, Zhendemedical's trading volume was 70,200 hands, with a total transaction amount of 504 million yuan [1]. - The net outflow of major funds was 31.21 million yuan, accounting for 6.19% of the total transaction amount, while retail investors saw a net inflow of 17.17 million yuan, representing 3.41% of the total [1][2]. - Over the past five days, the stock has seen fluctuations in net fund flows, with a notable net inflow of 106 million yuan on December 9, 2025, followed by a significant outflow on December 10 [2]. Group 2: Financing and Margin Trading Data - On December 10, 2025, the financing balance was 1.45 billion yuan, with a net repayment of 11.43 million yuan [3]. - The margin trading data indicates a total margin balance of 1.45 billion yuan, with a short selling of 600 shares and a remaining short position of 14,500 shares [3]. Group 3: Company Financials and Industry Comparison - For the first three quarters of 2025, Zhendemedical reported a main business revenue of 3.184 billion yuan, a year-on-year increase of 1.88%, but a net profit of 203 million yuan, down 33.91% year-on-year [5]. - The company's gross profit margin stands at 33.93%, significantly lower than the industry average of 51.22%, ranking 97th out of 124 in the medical device industry [5]. - Zhendemedical's total market capitalization is 19.239 billion yuan, with a price-to-earnings ratio of 71.01, which is higher than the industry average of 62.74 [5].